| Kalli Kline, | |
|
3526 Tongass Ave, Ketchikan, AK 99901-5635 | |
| (907) 225-6186 | |
| Not Available |
| Full Name | Kalli Kline |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3526 Tongass Ave, Ketchikan, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073110235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 163300 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kalli Kline, 3526 Tongass Ave, Ketchikan, AK 99901-5635 Ph: (907) 225-6186 | Kalli Kline, 3526 Tongass Ave, Ketchikan, AK 99901-5635 Ph: (907) 225-6186 |
News Archive
A preliminary study has shown for the first time that it may be possible to help people who have suffered partial damage to their spinal cord by applying a magnetic therapy to their brain.
A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
In a paper published in the Nature journal Scientific Reports, Saint Louis University researchers report that a new drug reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of Duchenne muscular dystrophy (DMD), providing a promising approach in designing new medications for those suffering from DMD.
The first time that many patients realise that diabetes can affect their kidneys is when they are referred to renal services, according to a multi-cultural study in the March issue of the Journal of Renal Care.
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
› Verified 7 days ago
Maxx Ritchie Keizer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 | |
Jacob Pignone, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2417 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-1960 Fax: 907-228-1919 | |
Kristin Frye, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4230 Don King Rd, Ketchikan, AK 99901 Phone: 907-247-2183 Fax: 907-247-2187 | |
Dr. Liliana B Boardman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 Fax: 907-228-5232 | |
Danielle Steepe, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4230 Don King Rd, Ketchikan, AK 99901 Phone: 907-247-2183 | |
Torrie Jayne Borch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3526 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-6186 |